0001235802-22-000113.txt : 20221011
0001235802-22-000113.hdr.sgml : 20221011
20221011164827
ACCESSION NUMBER: 0001235802-22-000113
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221007
FILED AS OF DATE: 20221011
DATE AS OF CHANGE: 20221011
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vizirgianakis Stavros G.
CENTRAL INDEX KEY: 0001559834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34951
FILM NUMBER: 221304572
MAIL ADDRESS:
STREET 1: 1/16-18 TENNYSON ST.
CITY: WILLIAMSTOWN NORTH, VICTORIA
STATE: CA
ZIP: 3016
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Xtant Medical Holdings, Inc.
CENTRAL INDEX KEY: 0001453593
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205313323
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 664 CRUISER LANE
CITY: BELGRADE
STATE: MT
ZIP: 59714
BUSINESS PHONE: 406-388-0480
MAIL ADDRESS:
STREET 1: 664 CRUISER LANE
CITY: BELGRADE
STATE: MT
ZIP: 59714
FORMER COMPANY:
FORMER CONFORMED NAME: Bacterin International Holdings, Inc.
DATE OF NAME CHANGE: 20100615
FORMER COMPANY:
FORMER CONFORMED NAME: K KITZ INC
DATE OF NAME CHANGE: 20090108
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2022-10-07
0
0001453593
Xtant Medical Holdings, Inc.
XTNT
0001559834
Vizirgianakis Stavros G.
664 CRUISER LANE
BELGRADE
MT
59714
1
0
0
0
Common Stock, $0.000001 par value
2022-10-07
4
P
0
2264861
0.48
A
5850716
D
Warrant
0.48
2022-10-07
4
P
0
566214
0
A
2022-10-07
2027-08-25
Common Stock
566214
566214
D
These shares were issued in a second and final tranche of a private placement pursuant to a securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
Includes 70,776 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
This warrant was issued in a second and final tranche of a private placement pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors.
This total does not include a warrant to purchase 878,770 shares of common stock issued on August 25, 2022. Such warrant was immediately exercisable as of the date of issuance and previously reported by the Reporting Person on a Form 4 filed with the Securities and Exchange Commission on August 26, 2022.
/s/ Amy Culbert, attorney-in-fact
2022-10-11